Requires food manufacturers to disclose new food additives not reported to FDA.
Impact
If enacted, S4748 would significantly alter how food additives are regulated in New Jersey, imposing stricter requirements on manufacturers to disclose information previously not mandated. The bill empowers the Commissioner of Health to create rules for compliance and aims to maintain a public database of the reported additives, bolstering transparency in food safety. Penalties for non-compliance could reach up to $5,000 for recurrent offenses, highlighting the bill's enforcement mechanism designed to deter lapses in reporting. This law represents a shift towards greater safety and transparency in food production, reflecting a growing public demand for more control over food safety standards.
Summary
Senate Bill 4748 aims to enhance the disclosure requirements for food manufacturers in New Jersey regarding new food additives not reported to the FDA. It stipulates that any manufacturer intending to use a new additive deemed 'generally recognized as safe' (GRAS) must notify the Department of Health via an annual report. This report must include a variety of specifics to ensure the additive's safety, including its method of manufacture, expected uses, and assurances regarding the availability of safety data for verification. The overarching intent of the bill is to empower consumers by making additive information publicly accessible, enabling them to make informed choices about the products they consume.
Contention
While the bill receives support for its consumer protection goals, there are potential points of contention regarding its enforcement and the burden it places on manufacturers. Critics may argue that the requirements could impose an undue burden, particularly on smaller food producers, potentially limiting their ability to innovate. Furthermore, the delineation of what qualifies as GRAS and the potential implications for proprietary data may raise concerns within the industry. Stakeholders may seek clarification on the specifics of the reporting requirements to address fears about compliance complexity and the potential for punitive measures.
Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25